Protein Disulfide Isomerase Inhibition Synergistically Enhances the Efficacy of Sorafenib for Hepatocellular Carcinoma

Hepatology - United States
doi 10.1002/hep.29237
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Sorafenib and Carfilzomib Synergistically Inhibit the Proliferation, Survival and Metastasis of Hepatocellular Carcinoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Sorafenib in Hepatocellular Carcinoma

Clinical Medicine. Therapeutics
2009English

Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Downregulation of Protein Disulfide‑isomerase A3 Expression Inhibits Cell Proliferation and Induces Apoptosis Through STAT3 Signaling in Hepatocellular Carcinoma

International Journal of Oncology
Cancer ResearchOncology
2019English

The Human Protein Disulfide Isomerase Gene Family

Human Genomics
Molecular MedicineDrug DiscoveryGeneticsMolecular Biology
2012English

A New Antithrombotic Strategy: Inhibition of the C-Terminal Active Site of Protein Disulfide Isomerase

Journal of Thrombosis and Haemostasis
MedicineHematology
2017English

Sorafenib Increases Efficacy of Vorinostat Against Human Hepatocellular Carcinoma Through Transduction Inhibition of Vorinostat-Induced ERK/NF-κB Signaling

International Journal of Oncology
Cancer ResearchOncology
2014English

Organocatalysts of Oxidative Protein Folding Inspired by Protein Disulfide Isomerase

Organic and Biomolecular Chemistry
Organic ChemistryTheoretical ChemistryBiochemistryPhysical
2014English

Cytotoxicity of Sorafenib in Human Hepatocellular Carcinoma Cells

Al-Azhar Journal of Pharmaceutical Sciences
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy